ALDEYRA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 1.32 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 1.01M shares, a 786.33% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 303.17K shares, a 125.42% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 248.82K shares, a 38.31% increase from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 179.90K shares, a 78.39% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 100.84K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.32M shares 10-Q · filed 2026-08-06 | 1.32M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.32M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 303.17K shares 10-Q · filed 2026-05-07 | 303.17K shares derived: sum of 2 quarters · filed 2026-05-07 | 303.17K shares derived: sum of 3 quarters · filed 2026-05-07 | 417.50K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 114.33K shares derived: sum of 3 quarters · filed 2026-02-27 | 248.82K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 114.33K shares derived: sum of 2 quarters · filed 2025-11-05 | 248.82K shares 10-Q · filed 2025-11-05 | 248.82K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 114.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 248.82K shares 10-Q · filed 2025-08-07 | 248.82K shares derived: sum of 3 quarters · filed 2025-08-07 | 248.82K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 134.49K shares 10-Q · filed 2025-05-14 | 134.49K shares derived: sum of 2 quarters · filed 2025-05-14 | 134.49K shares derived: sum of 3 quarters · filed 2025-05-14 | 259.22K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-28 | 124.73K shares derived: sum of 3 quarters · filed 2025-02-28 | 179.90K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 124.73K shares derived: sum of 2 quarters · filed 2024-11-07 | 179.90K shares 10-Q · filed 2024-11-07 | 275.94K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 124.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 179.90K shares 10-Q · filed 2024-08-01 | 275.94K shares derived: sum of 3 quarters · filed 2024-08-01 | |
| 2024-03-31 | 55.16K shares 10-Q · filed 2024-05-02 | 151.21K shares derived: sum of 2 quarters · filed 2024-05-02 | ||
| 2023-12-31 | 96.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 100.84K shares 10-K · filed 2024-03-07 | ||
| 2023-09-30 | 4.80K shares 10-Q · filed 2023-11-03 | |||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 75.84K shares 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | 75.84K shares 10-Q · filed 2020-08-06 | |||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-14 | 0.00 shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | 0.00 shares 10-Q · filed 2016-08-10 | ||
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |